MEDIFAST INC
MED
NYSE
MED
MEDIFAST INC NYSE
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
MED fundamentals
MEDIFAST INC financial statements, including revenue, expenses, profit, and loss
The total revenue of MED for the last quarter is 417.60M USD, and it's 10.52% higher compared to the previous quarter. The net income of Q1 22 is 41.78M USD.
Total revenue
Net income
TTM
Gross profit
—
—
—
—
—
—
—
Total revenue
—
—
—
—
—
—
—
Cost of goods sold
—
—
—
—
—
—
—
Operating expenses (excl. COGS)
—
—
—
—
—
—
—
Operating income
—
—
—
—
—
—
—
Non-operating income, total
—
—
—
—
—
—
—
Pretax income
—
—
—
—
—
—
—
Equity in earnings
—
—
—
—
—
—
—
Taxes
—
—
—
—
—
—
—
Non-controlling/minority interest
—
—
—
—
—
—
—
After tax other income/expense
—
—
—
—
—
—
—
Net income before discontinued operations
—
—
—
—
—
—
—
Discontinued operations
—
—
—
—
—
—
—
Net income
—
—
—
—
—
—
—
Dilution adjustment
—
—
—
—
—
—
—
Preferred dividends
—
—
—
—
—
—
—
Diluted net income available to common stockholders
—
—
—
—
—
—
—
Basic earnings per share (Basic EPS)
—
—
—
—
—
—
—
Diluted earnings per share (Diluted EPS)
—
—
—
—
—
—
—
Average basic shares outstanding
—
—
—
—
—
—
—
Diluted shares outstanding
—
—
—
—
—
—
—
EBITDA
—
—
—
—
—
—
—
EBIT
—
—
—
—
—
—
—
Total operating expenses
—
—
—
—
—
—
—